Increasing evidence supports that, similar to TGF-β, activin signaling plays a tumor-suppressive role in the early stage of pancreatic tumorigenesis, but switches to be a promoter in invasive pancreatic cancer. The gene discussed is TGFB1; the disease is pancreatic neoplasm.